Skip to main content

Table 5 Comparison between severe septic patients with and without IFI in the matched cohort study

From: Impact of invasive fungal infection on outcomes of severe sepsis: a multicenter matched cohort study in critically ill surgical patients

Variable

Severe sepsis patients with IFI (n = 60)

Severe sepsis patients without IFI (n = 60)

P value

Baseline descriptors

   

   Age (years; mean [IQR])

67.5 (52.25–75.75)

68 (54–74)

NS

   Admission APACHE II score (mean [IQR])

20 (16.25–25)

20 (16.25–23.75)

NS

   Admission SOFA score (mean [IQR])

8 (6–10.75)

8 (5–12)

NS

   Co-morbidity (n [%])

47 (78.3%)

48 (80.0%)

NS

   Cancer (n [%])

9 (15.0%)

11 (18.3%)

NS

   Diabetes mellitus (n [%])

10 (16.7%)

9 (15.0%)

NS

Interventions

   

   Mechanical ventilation (n [%])

49 (81.7%)

24 (40.0%)

<0.001

   Central venous catheterization (n [%])

51 (85.0%)

35 (58.3%)

<0.001

   Urinary catheterization (n [%])

58 (96.7%)

36 (60.0%)

<0.001

   Arterial catheterization (n [%])

41 (68.3%)

35 (58.3%)

NS

   Total parenteral nutrition (n [%])

35 (58.3%)

23 (38.3%)

0.036

   Corticosteroids or immunodepressant drugs (n [%])

13 (21.7%)

16 (26.7%)

NS

   Renal replacement therapy (n [%])

12 (20.0%)

11 (18.3%)

NS

Outcomes

   

   ICU LOS (days; mean [IQR])

17.5 (10–31)

6.5 (3–10)

<0.001

   Hospital LOS (days; mean [IQR])

30 (19.25–50)

20 (10.25–38.5)

0.020

   Mean daily costs ($; mean ± SD)

592 ± 326

469 ± 396

NS

   Hospital costs ($; mean ± SD)

17,951 ± 15,470

10,023 ± 12,347

0.038

   Hospital mortality (n [%])

42 (70.0%)

42 (50.0%)

0.023

  1. APACHE, Acute Physiology and Chronic Health Evaluation; ICU, intensive care unit; IQR, interquartile range; IFI, invasive fungal infection; LOS, length of stay; NS, not significant; SD, standard deviation; SOFA, Sequential Organ Failure Assessment.